Dusting vs Fragmentation Laser Cystolithotripsy for Pediatri... | Clinical Trial | StuddyBuddy@endsection Dusting vs Fragmentation Laser Cystolithotripsy for Pediatric Bladder Stones
Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT07623980

Dusting vs Fragmentation Laser Cystolithotripsy for Pediatric Bladder Stones

Conditions: Bladder Calculi, Pediatric Bladder Stones, Pediatric Urolithiasis

Sex: All
Ages: N/A – 18 Years
Healthy volunteers: No
Phase: NA
Enrollment: 110
Sponsor: Beni-Suef University

Location: Department of Urology- Beni-Suef University Hospitals Banī Suwayf Beni Suweif Governorate

Summary

Bladder stones are a clinically relevant pediatric urological condition that may require endoscopic treatment. Transurethral Holmium:YAG laser cystolithotripsy is a minimally invasive option for selected children with bladder stones. This prospective randomized trial will compare two Holmium:YAG laser strategies during transurethral cystolithotripsy in children with a single bladder stone less than 3 cm: dusting and fragmentation. Children will be randomized to undergo laser dusting or laser fragmentation during transurethral cystolithotripsy. The primary outcome is total operative time. Secondary outcomes include laser time, need for active fragment extraction, endoscopic stone-free status at the end of the procedure, ultrasound-assessed stone-free status during follow-up, intraoperative complications, postoperative urinary symptoms, urinary tract infection, need for postoperative catheterization, and hospital stay.

Eligibility Criteria

Inclusion Criteria: 1. Children aged less than 18 years. 2. Radiologically confirmed single bladder stone less than 3 cm. 3. Suitable for transurethral cystolithotripsy. 4. Fit for general anesthesia. 5. Written informed consent from parents or legal guardians. Exclusion Criteria: 1. Giant bladder stones more than 3 cm. 2. Urethral pathology preventing safe transurethral access. 3. Major lower urinary tract anomaly or neurogenic bladder. 4. Active untreated urinary tract infection. 5. Coagulation disorder or contraindication to endoscopic surgery.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07623980). StuddyBuddy aggregates publicly available trial information.